Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis

Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.

Authors

Shu-Yi Liao¹, Anthony N Gerber², Pearlanne Zelarney³, Barry Make², Michael E Wechsler²

Affiliations

¹ Department of Medicine, National Jewish Health, Denver, CO. Electronic address: liaos@NJHealth.org.
² Department of Medicine, National Jewish Health, Denver, CO.
³ Department of Academic Affairs, National Jewish Health, Denver, CO.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral
Antibody Formation
COVID-19 Vaccines
COVID-19*
Graft vs Host Disease*
Humans
SARS-CoV-2
Vaccination
Vaccines, Synthetic
mRNA Vaccines

Substances

Antibodies, Viral
COVID-19 Vaccines
Vaccines, Synthetic
mRNA Vaccine
mRNA Vaccines